| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.25 | 0.0002 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.28 | 0.0002 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0003 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0005 |